Skip to main content
Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes

Fig. 4

Gene expression of inflammation in the liver of the five groups. Normalized mRNA expression tumor necrosis factor (TNF) α (a), monocyte chemoattractant protein (MCP)-1 (b), interleukin (IL)-6 (c), and suppressor of cytokine signaling (SOC)-3 (d). Data are mean ± SE. *P < 0.05 vs. control; §P < 0.05, ||P < 0.01, P < 0.001 vs. vehicle; #P < 0.05, **P < 0.01 vs. Linagliptin alone

Back to article page